Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: neurotransmitter

July 27, 2026 CD as API / Pharma applications

Impact of Cholesterol Depletion by Methyl BCD on Dopamine Transmission Dynamics in Brain

Disrupted brain cholesterol homeostasis is implicated in neurological disorders involving aberrant dopamine (DA) signaling; however, the direct effects of cholesterol

Continue reading

March 12, 2022 Pharma applications / Supramolecular systems

Thiolated amphiphilic beta-cyclodextrin-decorated gold colloids: Synthesis, supramolecular nanoassemblies and controlled release of dopamine

We report a hybrid nanoassembly based on gold colloids decorated with a new thiolated amphiphilic cyclodextrin complexing dopamine (AuNPs@SC16SH/DA). The

Continue reading

September 27, 2021 Uncategorized

Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects more than 10 million people worldwide. Oxidative stress and mitochondrial

Continue reading

November 17, 2018 Drug delivery / Pharma applications

Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression

If approved, ZULRESSO would be the first medicine specifically indicated for the treatment of postpartum depression (PPD) Sage Therapeutics (NASDAQ:

Continue reading

Recent Posts

  • HPBCD–myrrh oil inclusion complex: enhancing solubility and antibacterial activity
  • Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels
  • New Trends in Cyclodextrins Technology for Pharmaceutical
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • Over 70,000 hits in Scopus for “cyclodextrin” keyword

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (359)
  • CD derivatives (438)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (822)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (237)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (421)
  • Other industrial use (114)
  • Pharma applications (1,228)
  • Supramolecular systems (44)
  • Uncategorized (170)

Top Posts

  • Impact of Threading State on the Mechanics of γ-Cyclodextrin–Pyrene Gels
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
  • Coatings of Cyclodextrin/Citric-Acid Biopolymer as Drug Delivery Systems: A Review
  • Cyclodextrin science helps dishes sparkle
  • Homage to Prof. Szejtli
  • Neostigmine vs. sugammadex: on postoperative nausea and vomiting (PONV) after general anaesthesia
  • HPBCD–myrrh oil inclusion complex: enhancing solubility and antibacterial activity
  • Novel polyrotaxane for Niemann Pick disease type C treatment
  • Eco-Friendly Nanoantibiotics: A New Approach to Combat Resistance

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...